|
|
|||||||||||
Pharmacy Department, Maudsley Hospital, Denmark Hill, London SE5 8AZ, tel: 020 7740 5040, e-mail: David.Taylor{at}slam.nhs.uk
AIMS AND METHOD
The National Institute for Clinical Excellence (NICE) has issued guidance on the use of atypical antipsychotic drugs and recommended that patients be involved in a discussion about the antipsychotic prescribed to them. We undertook a study to evaluate information provision and patient choice subsequent to the publication of this guidance. Patients were recruited from the South London and MaudsleyTrust and interviewed. Case notes were examined for documentation of informed discussions.
RESULTS
Thirty patients were interviewed, of whom 15 claimed to have received no information. Twenty-seven patients felt that they had had no choice in regard to antipsychotic prescribed. None of the patients had documentation in their notes to suggest that they were involved in informed discussions about the antipsychotic they were prescribed.
CLINICAL IMPLICATIONS
Patients were not involved in decisions regarding the antipsychotic medication prescribed. Practice did not follow the NICE guidance.
This article has been cited by other articles:
![]() |
R. Chaplin, P. Lelliott, A. Quirk, and C. Seale Negotiating styles adopted by consultant psychiatrists when prescribing antipsychotics Advan. Psychiatr. Treat., January 1, 2007; 13(1): 43 - 50. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| British Journal of Psychiatry | Advances in Psychiatric Treatment | All RCPsych Journals |